F. Cetta et al., THE RET PTC1 ONCOGENE IS ACTIVATED IN FAMILIAL ADENOMATOUS POLYPOSIS-ASSOCIATED THYROID PAPILLARY CARCINOMAS/, The Journal of clinical endocrinology and metabolism, 83(3), 1998, pp. 1003-1006
Familial adenomatous polyposis (FAP) is caused by germ-line mutations
of the ape gene, and it is associated with an increased risk of develo
ping papillary thyroid carcinomas. We have previously reported that a
significant fraction of sporadic human papillary thyroid carcinomas is
characterized by gene rearrangements affecting the ret protooncogene.
These rearrangements generate chimeric transforming oncogenes designa
ted ret/ptc. By a combined immunohistochemical and RT PCR approach, we
analyzed, for ret/ptc oncogene activation, papillary thyroid carcinom
as occurred in two FAP kindreds, both showing typical ape gene mutatio
ns. Kindred 1 had seven members affected by FAP, and among these, thre
e patients showed papillary thyroid carcinomas. Kindred 2 had two pati
ents, mother and daughter, affected by colonic polyposis; the 20-yr-ol
d daughter showed also a papillary carcinoma. Here we report that ret/
ptc1 oncogene was activated in two of the three papillary carcinomas o
f FAP kindred 1 and in the papillary carcinoma of FAP kindred 2. These
findings document that loss of function of ape coexists with gain of
function of ret in some papillary thyroid carcinomas, suggesting that
ret/ptc1 oncogene activation could be a progression step in the develo
pment of FAP-associated thyroid tumors.